Safety of egg membrane hydrolysate as a novel food pursuant to Regulation (EU) 2015/2283: (Scientific Opinion)

Research output: Contribution to journalJournal articleCommissionedpeer-review

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver a scientific opinion on egg membrane hydrolysate as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a water-soluble hydrolysate of egg membrane, produced by alkaline treatment of the thin layer lining the shells of chicken eggs. The main
constituents of the NF are elastin, collagen and glycosaminoglycans. The information provided on the production process, batch-to-batch variability, composition and specifications of the NF is sufficient and does not raise safety concerns. The NF is proposed to be used as a food supplement for adults, at a
maximum daily amount of 450 mg. The consumption of the NF is not nutritionally disadvantageous. One human study, which was not designed for safety but included a number of endpoints pertaining to safety, did not raise safety concerns. The Panel considers that taking into account the information
provided and considering the nature, the source and the production process of the NF, there are no safety concerns for the NF at the proposed conditions of use. The Panel concludes that the NF, egg membrane hydrolysate, is safe as a food supplement at a dose of 450 mg/day. The target population for the NF is the general adult population.
Original languageEnglish
Article number5363
JournalE F S A Journal
Volume16
Issue number7
Number of pages13
ISSN1831-4732
DOIs
Publication statusPublished - 23 Jul 2018

Bibliographical note

EFSA 2018 5363

Number of downloads are based on statistics from Google Scholar and www.ku.dk


No data available

ID: 201006831